| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| P. Kent Hawryluk | President CEO | 2026-03-13 | 18,500 | $28.41 | $525.66kBuy |
| P. Kent Hawryluk | President CEO | 2026-02-26 | 28,768 | $16.00 | $460.29kBuy |
| P. Kent Hawryluk | President CEO | 2025-10-24 | 182,859 | $3.25 | $594.29kBuy |
| P. Kent Hawryluk | President CEO | 2025-10-20 | 20,000 | $13.64 | $272.78kBuy |
| Steven L. Hoerter | Director | 2025-10-17 | 20,000 | $13.25 | $264.98kBuy |
| Patrick J. Heron | Director | 2025-09-26 | 666,666 | $18.00 | $12.00MBuy |
| Ora H. Pescovitz | Director | 2025-04-08 | 7,693 | $5.89 | $45.31kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Frazier Life Sciences Management LP | 14.00% | 6,652,013 | $190.78M | Institution |
| Patrick J. Heron | 10.99% | 5,219,440 | $149.69M | Insider |
| Orbimed Advisors LLC | 9.60% | 4,560,102 | $130.78M | Insider |
| Carl L. Gordon | 9.60% | 4,560,102 | $130.78M | Insider |
| Frazier Life Sciences X LP | 9.58% | 4,552,774 | $130.57M | Insider |
| Orbimed Advisors LLC | 8.28% | 3,935,203 | $112.86M | Institution |
| Edward T. Mathers | 7.61% | 3,614,486 | $103.66M | Insider |
| New Enterprise Associates 17 LP | 7.61% | 3,614,486 | $103.66M | Insider |
| Scott D. Sandell | 7.61% | 3,614,486 | $103.66M | Insider |
| Paul Edward Walker | 7.61% | 3,614,486 | $103.66M | Insider |